KIN stock forecast
Our latest prediction for Kindred Biosciences Inc's stock price was made on the June 16, 2021 when the stock price was at 9.23$.
In the short term (2weeks), KIN's stock price should underperform the market by -2.17%. During that period the price should oscillate between -11.44% and +17.68%.
In the medium term (3months), KIN's stock price should underperform the market by -8.38%. During that period the price should oscillate between -33.57% and +30.38%.Get email alerts
Create a solid portfolio with KIN
About Kindred Biosciences Inc
Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company’s strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.
At the moment the company generates 8M USD in revenues.
On its last earning announcement, the company reported a loss of -1.02$ per share.
The book value per share is 3.42$
Three months stock forecastJune 16, 2021
|Earnings Per Share
|Book Value Per Share
|Operating Cash Flow
|Free Cash Flow